ApexOnco and other media outlets reported that the FDA has placed a partial clinical hold on the phase III IDeate-Lung02 trial after more patients died from interstitial lung disease than anticipated; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback